What Researchers Did
Researchers conducted a 2-week randomized controlled study involving 36 diabetic foot ulcer patients, comparing standard care alone to standard care plus twice-daily hyperbaric oxygen therapy.
What They Found
The hyperbaric oxygen (HBO) group showed a significant increase in transcutaneous oxygen pressure (TcPo2) by day 7 (477.8 mm Hg vs 37.06 mm Hg, P <0.01) and day 14 (501.1 mm Hg vs 35.61 mm Hg, P <0.01) compared to baseline. This group also experienced greater ulcer size reduction.
What This Means for Canadian Patients
Canadian patients with diabetic foot ulcers might benefit from hyperbaric oxygen therapy as an adjunct to standard care, potentially leading to improved wound healing. This could reduce complications and improve quality of life for those suffering from chronic foot ulcers.
Canadian Relevance
This study does not have a direct Canadian connection.
Study Limitations
The study's short 2-week duration and small sample size of 36 patients limit the generalizability and long-term implications of the findings.